Treatment of wheezing
Pro Research Analysisby 
Searched over 200M research papers
Wheezing Treatment Approaches in Children and Adults
Wheezing Phenotypes and Initial Assessment
Wheezing in children, especially preschoolers, is commonly classified into two main types: episodic (viral) wheeze, where symptoms occur only during infections, and multiple-trigger wheeze, where symptoms can happen at any time. However, these categories often overlap, and children may switch between them over time, making strict classification difficult and sometimes unnecessary for treatment decisions Brand2008Brand2014.
First-Line Treatments: Inhaled Beta2-Agonists and Corticosteroids
For immediate symptom relief, inhaled short-acting beta2-agonists (such as albuterol) delivered via a metered-dose inhaler with a spacer are recommended for all children with wheezing Brand2008Brand2014. Inhaled corticosteroids are the first-choice maintenance therapy for children with multiple-trigger wheeze and can also be considered for those with frequent or severe episodic viral wheeze. These should be used as a treatment trial and discontinued if there is no clear benefit Brand2008Brand2014Fainardi2020.
Montelukast and Leukotriene Modifiers
Montelukast, a leukotriene receptor antagonist, is recommended for episodic (viral) wheeze and can be started at the onset of cold symptoms. Leukotriene modifiers may be helpful in select preschool children, but their benefits are generally modest Brand2008Stokes2020Fainardi2020.
Anticholinergic Therapies
Anticholinergic drugs like ipratropium bromide are sometimes used, especially in combination with beta2-agonists. Evidence suggests that this combination can reduce the need for additional treatment, but overall benefits are limited, and routine use is not strongly supported . Newer anticholinergic agents, such as tiotropium bromide, have shown promise in increasing episode-free days in young children with episodic wheezing, but more research is needed before widespread adoption .
Oral Corticosteroids
Oral corticosteroids are not recommended for mild-to-moderate wheezing episodes and should be reserved for severe exacerbations requiring hospitalization Brand2014Stokes2020.
Bacterial Lysate and Immunotherapy
Emerging evidence supports the use of bacterial lysate therapies, such as MV130, for reducing the frequency and duration of wheezing episodes in children, particularly those with recurrent viral-induced wheeze. These therapies work by modulating the immune response and have shown reductions in wheezing attacks, medication use, and antibiotic need Abrams2019Nieto2021De Boer2020.
Azithromycin and Other Emerging Therapies
Azithromycin, an antibiotic with anti-inflammatory properties, has been shown to reduce the risk of severe lower respiratory tract illnesses and decrease the duration of wheeze in preschool children. However, more research is needed to define its optimal use Abrams2019Stokes2020.
Non-Pharmacological and Adjuvant Therapies
Educating parents about triggers and treatment, avoiding tobacco smoke exposure, and considering allergen avoidance in sensitized children are important supportive measures . In adults with chronic obstructive pulmonary disease (COPD), auricular acupressure (a traditional Chinese medicine technique) has been used as an adjuvant therapy to relieve wheezing symptoms, though evidence is limited to case studies .
Conclusion
The treatment of wheezing, especially in young children, should be individualized based on symptom patterns, severity, and response to therapy. Inhaled beta2-agonists and corticosteroids remain the mainstays of treatment, with montelukast and bacterial lysate therapies offering additional options for select patients. New therapies, such as tiotropium and azithromycin, show promise but require further study. Non-pharmacological strategies and parent education are also key components of effective management.
Sources and full results
Most relevant research papers on this topic
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
Preschool children with wheezing disorders should be treated with inhaled 2-agonists, avoid tobacco smoke, and consider allergen avoidance.
Classification and pharmacological treatment of preschool wheezing: changes since 2008
The distinction between episodic viral and multiple-trigger wheeze in preschool children is unclear, and inhaled corticosteroids remain the first-line treatment for multiple-trigger wheeze.
Prevention and Treatment of Recurrent Viral-Induced Wheeze in the Preschool Child.
Inhaled corticosteroids, leukotriene modifying agents, and azithromycin effectively reduce viral-induced wheezing in preschool children, with further research needed to optimize treatment strategies.
DOI